A one-year randomized trial found that daily prune supplementation did not improve total or lumbar spine bone mineral density ...
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that ...
Morning Overview on MSN
A daily multivitamin just slowed all five epigenetic aging clocks in a randomized trial — the people who started biologically older showed the biggest benefit
A two-year randomized trial found that a daily multivitamin slowed biological aging across all five epigenetic clocks tested ...
PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision medicine treatment in DEDThis FDA-aligned trial targets ...
The 2026 ASCO annual meeting featured a prostate cancer trials in progress session and a presentation by Dr. Michael Ong discussing TRIPLE-SWITCH (SWOG/CCTG-PR26), a randomized phase III clinical ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
LTI-03 in idiopathic pulmonary fibrosis (IPF)First patient randomized in the United KingdomClinical trial sites now actively ...
Radiographic progression free survival (RECIST 1.1 and PCWG3) CTCAE v5.0 ...
Morning Overview on MSN
A daily multivitamin slowed all five epigenetic aging clocks in a randomized trial — people who started biologically older saw the biggest benefit
A standard daily multivitamin, the kind sold at every pharmacy for roughly a dime a dose, slowed biological aging across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results